-
1
-
-
34248136340
-
Inflammatory bowel disease: Clinical aspects and established and evolving therapies
-
Baumgart DC, Sandborn WJ,. Inflammatory bowel disease: Clinical aspects and established and evolving therapies. Lancet 2007; 369: 1641-1657.
-
(2007)
Lancet
, vol.369
, pp. 1641-1657
-
-
Baumgart, D.C.1
Sandborn, W.J.2
-
2
-
-
84940948700
-
Immunoregulatory pathways involved in inflammatory bowel disease
-
Fonseca-Camarillo G, Yamamoto-Furusho JK,. Immunoregulatory pathways involved in inflammatory bowel disease. Inflamm Bowel Dis 2015; 21: 2188-2193.
-
(2015)
Inflamm Bowel Dis
, vol.21
, pp. 2188-2193
-
-
Fonseca-Camarillo, G.1
Yamamoto-Furusho, J.K.2
-
3
-
-
84961795013
-
Emerging trends of inflammatory bowel disease in Asia
-
Ng SC,. Emerging trends of inflammatory bowel disease in Asia. Gastroenterol Hepatol (N Y) 2016; 12: 193-196.
-
(2016)
Gastroenterol Hepatol (N Y)
, vol.12
, pp. 193-196
-
-
Ng, S.C.1
-
4
-
-
84859440796
-
HMGB1: A multifunctional alarmin driving autoimmune and inflammatory disease
-
Harris HE, Andersson U, Pisetsky DS,. HMGB1: A multifunctional alarmin driving autoimmune and inflammatory disease. Nat Rev Rheumatol 2012; 8: 195-202.
-
(2012)
Nat Rev Rheumatol
, vol.8
, pp. 195-202
-
-
Harris, H.E.1
Andersson, U.2
Pisetsky, D.S.3
-
5
-
-
0037062934
-
Release of chromatin protein HMGB1 by necrotic cells triggers inflammation
-
Scaffidi P, Misteli T, Bianchi ME,. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 2002; 418: 191-195.
-
(2002)
Nature
, vol.418
, pp. 191-195
-
-
Scaffidi, P.1
Misteli, T.2
Bianchi, M.E.3
-
6
-
-
84896380925
-
Recent developments in the role of high-mobility group box 1 in systemic lupus erythematosus
-
Schaper F, Westra J, Bijl M,. Recent developments in the role of high-mobility group box 1 in systemic lupus erythematosus. Mol Med 2014; 20: 72-79.
-
(2014)
Mol Med
, vol.20
, pp. 72-79
-
-
Schaper, F.1
Westra, J.2
Bijl, M.3
-
7
-
-
84887385152
-
The role of high mobility group box chromosomal protein 1 in rheumatoid arthritis
-
Chen Y, Sun W, Gao R, et al. The role of high mobility group box chromosomal protein 1 in rheumatoid arthritis. Rheumatology 2013; 52: 1739-1747.
-
(2013)
Rheumatology
, vol.52
, pp. 1739-1747
-
-
Chen, Y.1
Sun, W.2
Gao, R.3
-
8
-
-
84966409216
-
Inflammatory response and immune regulation of high mobility group box-1 protein in treatment of sepsis
-
Liu QY, Yao YM,. Inflammatory response and immune regulation of high mobility group box-1 protein in treatment of sepsis. World J Emerg Med 2010; 1: 93-98.
-
(2010)
World J Emerg Med
, vol.1
, pp. 93-98
-
-
Liu, Q.Y.1
Yao, Y.M.2
-
9
-
-
1542380035
-
Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein
-
Park JS, Svetkauskaite D, He Q, et al. Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J Biol Chem 2004; 279: 7370-7377.
-
(2004)
J Biol Chem
, vol.279
, pp. 7370-7377
-
-
Park, J.S.1
Svetkauskaite, D.2
He, Q.3
-
10
-
-
84907833448
-
The role of TLR2 and 4-mediated inflammatory pathways in endothelial cells exposed to high glucose
-
Mudaliar H, Pollock C, Ma J, et al. The role of TLR2 and 4-mediated inflammatory pathways in endothelial cells exposed to high glucose. PloS One 2014; 9: e108844-e108844.
-
(2014)
PloS One
, vol.9
, pp. e108844-e108844
-
-
Mudaliar, H.1
Pollock, C.2
Ma, J.3
-
11
-
-
84903397357
-
Polymorphisms in the inflammatory pathway genes TLR2, TLR4, TLR9, LY96, NFKBIA, NFKB1, TNFA, TNFRSF1A, IL6R, IL10, IL23R, PTPN22, and PPARG are associated with susceptibility of inflammatory bowel disease in a Danish cohort
-
Bank S, Skytt Andersen P, Burisch J, et al. Polymorphisms in the inflammatory pathway genes TLR2, TLR4, TLR9, LY96, NFKBIA, NFKB1, TNFA, TNFRSF1A, IL6R, IL10, IL23R, PTPN22, and PPARG are associated with susceptibility of inflammatory bowel disease in a Danish cohort. PloS One 2014; 9: e98815-e98815.
-
(2014)
PloS One
, vol.9
, pp. e98815-e98815
-
-
Bank, S.1
Skytt Andersen, P.2
Burisch, J.3
-
12
-
-
84932618647
-
Association between TLR2 and TLR4 gene polymorphisms and the susceptibility to inflammatory bowel disease: A meta-analysis
-
Cheng Y, Zhu Y, Huang X, et al. Association between TLR2 and TLR4 gene polymorphisms and the susceptibility to inflammatory bowel disease: A meta-analysis. PloS One 2015; 10: e0126803-e0126803.
-
(2015)
PloS One
, vol.10
, pp. e0126803-e0126803
-
-
Cheng, Y.1
Zhu, Y.2
Huang, X.3
-
13
-
-
84918528098
-
Baicalin down regulates the expression of TLR4 and NFkB-p65 in colon tissue in mice with colitis induced by dextran sulfate sodium
-
Feng J, Guo C, Zhu Y, et al. Baicalin down regulates the expression of TLR4 and NFkB-p65 in colon tissue in mice with colitis induced by dextran sulfate sodium. Int J Clin Exp Med 2014; 7: 4063-4072.
-
(2014)
Int J Clin Exp Med
, vol.7
, pp. 4063-4072
-
-
Feng, J.1
Guo, C.2
Zhu, Y.3
-
14
-
-
80655127791
-
Fecal HMGB1 is a novel marker of intestinal mucosal inflammation in pediatric inflammatory bowel disease
-
Vitali R, Stronati L, Negroni A, et al. Fecal HMGB1 is a novel marker of intestinal mucosal inflammation in pediatric inflammatory bowel disease. Am J Gastroenterol 2011; 106: 2029-2040.
-
(2011)
Am J Gastroenterol
, vol.106
, pp. 2029-2040
-
-
Vitali, R.1
Stronati, L.2
Negroni, A.3
-
15
-
-
68049094195
-
Bile high-mobility group box 1 contributes to gut barrier dysfunction in experimental endotoxemia
-
Yang R, Miki K, Oksala N, et al. Bile high-mobility group box 1 contributes to gut barrier dysfunction in experimental endotoxemia. Am J Physiol Regul Integr Comp Physiol 2009; 297: R362-R369.
-
(2009)
Am J Physiol Regul Integr Comp Physiol
, vol.297
, pp. R362-R369
-
-
Yang, R.1
Miki, K.2
Oksala, N.3
-
16
-
-
84886091299
-
Innate lymphoid cells in homeostasis, infection, chronic inflammation and tumors of the gastrointestinal tract
-
Fuchs A, Colonna M,. Innate lymphoid cells in homeostasis, infection, chronic inflammation and tumors of the gastrointestinal tract. Curr Opin Gastroenterol 2013; 29: 581-587.
-
(2013)
Curr Opin Gastroenterol
, vol.29
, pp. 581-587
-
-
Fuchs, A.1
Colonna, M.2
-
17
-
-
84872977452
-
Innate lymphoid cells - A proposal for uniform nomenclature
-
Spits H, Artis D, Colonna M, et al. Innate lymphoid cells-a proposal for uniform nomenclature. Nat Rev Immunol 2013; 13: 145-149.
-
(2013)
Nat Rev Immunol
, vol.13
, pp. 145-149
-
-
Spits, H.1
Artis, D.2
Colonna, M.3
-
18
-
-
84898640432
-
Differentiation of type 1 ILCs from a common progenitor to all helper-like innate lymphoid cell lineages
-
Klose CS, Flach M, Möhle L, et al. Differentiation of type 1 ILCs from a common progenitor to all helper-like innate lymphoid cell lineages. Cell 2014; 157: 340-356.
-
(2014)
Cell
, vol.157
, pp. 340-356
-
-
Klose, C.S.1
Flach, M.2
Möhle, L.3
-
19
-
-
84867769688
-
The transcription factor GATA-3 controls cell fate and maintenance of type 2 innate lymphoid cells
-
Hoyler T, Klose CS, Souabni A, et al. The transcription factor GATA-3 controls cell fate and maintenance of type 2 innate lymphoid cells. Immunity 2012; 37: 634-648.
-
(2012)
Immunity
, vol.37
, pp. 634-648
-
-
Hoyler, T.1
Klose, C.S.2
Souabni, A.3
-
20
-
-
84900867028
-
Recognition strategies of group 3 innate lymphoid cells
-
Killig M, Glatzer T, Romagnani C,. Recognition strategies of group 3 innate lymphoid cells. Front Immunol 2014; 5: 142-142.
-
(2014)
Front Immunol
, vol.5
, pp. 142
-
-
Killig, M.1
Glatzer, T.2
Romagnani, C.3
-
21
-
-
60549102720
-
Lymphoid tissue inducer-like cells are an innate source of IL-17 and IL-22
-
Takatori H, Kanno Y, Watford WT, et al. Lymphoid tissue inducer-like cells are an innate source of IL-17 and IL-22. J Exp Med 2009; 206: 35-41.
-
(2009)
J Exp Med
, vol.206
, pp. 35-41
-
-
Takatori, H.1
Kanno, Y.2
Watford, W.T.3
-
22
-
-
78049385155
-
Lineage relationship analysis of RORgammat+ innate lymphoid cells
-
Sawa S, Cherrier M, Lochner M, et al. Lineage relationship analysis of RORgammat+ innate lymphoid cells. Science 2010; 330: 665-669.
-
(2010)
Science
, vol.330
, pp. 665-669
-
-
Sawa, S.1
Cherrier, M.2
Lochner, M.3
-
23
-
-
84870876967
-
Th22 cells are an important source of IL-22 for host protection against enteropathogenic bacteria
-
Basu R, O'Quinn DB, Silberger DJ, et al. Th22 cells are an important source of IL-22 for host protection against enteropathogenic bacteria. Immunity 2012; 37: 1061-1075.
-
(2012)
Immunity
, vol.37
, pp. 1061-1075
-
-
Basu, R.1
O'Quinn, D.B.2
Silberger, D.J.3
-
25
-
-
79958277385
-
IL-23-responsive innate lymphoid cells are increased in inflammatory bowel disease
-
Geremia A, Arancibia-Cárcamo CV, Fleming MPP, et al. IL-23-responsive innate lymphoid cells are increased in inflammatory bowel disease. J Exp Med 2011; 208: 1127-1133.
-
(2011)
J Exp Med
, vol.208
, pp. 1127-1133
-
-
Geremia, A.1
Arancibia-Cárcamo, C.V.2
Fleming, M.P.P.3
-
26
-
-
77951878587
-
Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology
-
Buonocore S, Ahern PP, Uhlig HH, et al. Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology. Nature 2010; 464: 1371-1375.
-
(2010)
Nature
, vol.464
, pp. 1371-1375
-
-
Buonocore, S.1
Ahern, P.P.2
Uhlig, H.H.3
-
27
-
-
83655183007
-
Opposing consequences of IL-23 signaling mediated by innate and adaptive cells in chemically induced colitis in mice
-
Cox JH, Kljavin NM, Ota N, et al. Opposing consequences of IL-23 signaling mediated by innate and adaptive cells in chemically induced colitis in mice. Mucosal Immunol 2012; 5: 99-109.
-
(2012)
Mucosal Immunol
, vol.5
, pp. 99-109
-
-
Cox, J.H.1
Kljavin, N.M.2
Ota, N.3
-
28
-
-
84904624900
-
HMGB1 is involved in chronic rejection of cardiac allograft via promoting inflammatory-like mDCs
-
Zou H, Yang Y, Gao M, et al. HMGB1 is involved in chronic rejection of cardiac allograft via promoting inflammatory-like mDCs. Am J Transplant 2014; 14: 1765-1777.
-
(2014)
Am J Transplant
, vol.14
, pp. 1765-1777
-
-
Zou, H.1
Yang, Y.2
Gao, M.3
-
29
-
-
0030239820
-
Hapten-induced model of murine inflammatory bowel disease: Mucosa immune responses and protection by tolerance
-
Elson CO, Beagley KW, Sharmanov AT, et al. Hapten-induced model of murine inflammatory bowel disease: Mucosa immune responses and protection by tolerance. J Immunol 1996; 157: 2174-2185.
-
(1996)
J Immunol
, vol.157
, pp. 2174-2185
-
-
Elson, C.O.1
Beagley, K.W.2
Sharmanov, A.T.3
-
30
-
-
34447108927
-
Essential roles of high-mobility group box 1 in the development of murine colitis and colitis-associated cancer
-
Maeda S, Hikiba Y, Shibata W, et al. Essential roles of high-mobility group box 1 in the development of murine colitis and colitis-associated cancer. Biochem Biophys Res Commun 2007; 360: 394-400.
-
(2007)
Biochem Biophys Res Commun
, vol.360
, pp. 394-400
-
-
Maeda, S.1
Hikiba, Y.2
Shibata, W.3
-
31
-
-
84954290481
-
Group 3 innate lymphoid cells: Regulating host-commensal bacteria interactions in inflammation and cancer
-
Goc J, Hepworth MR, Sonnenberg GF,. Group 3 innate lymphoid cells: Regulating host-commensal bacteria interactions in inflammation and cancer. Int Immunol 2016; 28: 43-52.
-
(2016)
Int Immunol
, vol.28
, pp. 43-52
-
-
Goc, J.1
Hepworth, M.R.2
Sonnenberg, G.F.3
-
32
-
-
84923037996
-
Expression of Toll-like receptors in the mucosa of patients with ulcerative colitis
-
Fan Y, Liu B,. Expression of Toll-like receptors in the mucosa of patients with ulcerative colitis. Exp Ther Med 2015; 9: 1455-1459.
-
(2015)
Exp Ther Med
, vol.9
, pp. 1455-1459
-
-
Fan, Y.1
Liu, B.2
-
33
-
-
78650183459
-
Regulation of cytokine secretion in human CD127(+) LTi-like innate lymphoid cells by Toll-like receptor 2
-
Crellin NK, Trifari S, Kaplan CD, et al. Regulation of cytokine secretion in human CD127(+) LTi-like innate lymphoid cells by Toll-like receptor 2. Immunity 2010; 33: 752-764.
-
(2010)
Immunity
, vol.33
, pp. 752-764
-
-
Crellin, N.K.1
Trifari, S.2
Kaplan, C.D.3
-
34
-
-
9644291539
-
IL-12 and IL-23: Master regulators of innate and adaptive immunity
-
Langrish CL, McKenzie BS, Wilson NJ, et al. IL-12 and IL-23: Master regulators of innate and adaptive immunity. Immunol Rev 2004; 202: 96-105.
-
(2004)
Immunol Rev
, vol.202
, pp. 96-105
-
-
Langrish, C.L.1
McKenzie, B.S.2
Wilson, N.J.3
-
35
-
-
70149106605
-
Ethyl pyruvate decreases HMGB1 release and ameliorates murine colitis
-
Dave SH, Tilstra JS, Matsuoka K, et al. Ethyl pyruvate decreases HMGB1 release and ameliorates murine colitis. J Leukoc Biol 2009; 86: 633-643.
-
(2009)
J Leukoc Biol
, vol.86
, pp. 633-643
-
-
Dave, S.H.1
Tilstra, J.S.2
Matsuoka, K.3
-
36
-
-
0036724929
-
HMGB1 B box increases the permeability of Caco-2 enterocytic monolayers and impairs intestinal barrier function in mice
-
Sappington PL, Yang R, Yang H, et al. HMGB1 B box increases the permeability of Caco-2 enterocytic monolayers and impairs intestinal barrier function in mice. Gastroenterology 2002; 123: 790-802.
-
(2002)
Gastroenterology
, vol.123
, pp. 790-802
-
-
Sappington, P.L.1
Yang, R.2
Yang, H.3
-
37
-
-
84905446363
-
Role of HMGB1 as a suitable biomarker of subclinical intestinal inflammation and mucosal healing in patients with inflammatory bowel disease
-
Palone F, Vitali R, Cucchiara S, et al. Role of HMGB1 as a suitable biomarker of subclinical intestinal inflammation and mucosal healing in patients with inflammatory bowel disease. Inflamm Bowel Dis 2014; 20: 1448-1457.
-
(2014)
Inflamm Bowel Dis
, vol.20
, pp. 1448-1457
-
-
Palone, F.1
Vitali, R.2
Cucchiara, S.3
-
39
-
-
67650234634
-
IL-22: A two-headed cytokine in IBD?
-
Seiderer J, Brand S,. IL-22: A two-headed cytokine in IBD? Inflamm Bowel Dis 2009; 15: 473-474.
-
(2009)
Inflamm Bowel Dis
, vol.15
, pp. 473-474
-
-
Seiderer, J.1
Brand, S.2
-
40
-
-
84879571464
-
Innate lymphoid cells sustain colon cancer through production of interleukin-22 in a mouse model
-
Kirchberger S, Royston DJ, Boulard O, et al. Innate lymphoid cells sustain colon cancer through production of interleukin-22 in a mouse model. J Exp Med 2013; 210: 917-931.
-
(2013)
J Exp Med
, vol.210
, pp. 917-931
-
-
Kirchberger, S.1
Royston, D.J.2
Boulard, O.3
|